ClinicalTrialsFinder
CompletedPhase 2Phase 3ACTRN12605000303640

Dose response study of phytosterols in tablet dosage in adults with primary hypercholeterolemia

Randomised, four arm, double blind placebo controlled dose response study of phytosterols in tablet dosage in adults with primary hypercholesterolemia

Sponsor

Mayne Health Consumer Products

Enrollment

80 participants

Start Date

Jul 8, 2002

Study Type

Interventional

Conditions

Primary hypercholesterolemia

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 75 Yearss

Plain Language Summary

Simplified for easier understanding

This study is about dose response study of phytosterols in tablet dosage in adults with primary hypercholeterolemia. It may be open to people between 18 years old and 75 years old. Participants generally need to have ldl cholesterol greater then or equal to 3.5mmol/l and less than or equal to 5.7 mmol/l.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The study compared baseline levels of lipids with post-treatment lipid levels for placebo and three concentrations of phytosterols(900mg/day or 1800mg/day or 2700mg/day) following 12 weeks of treatmen

The study compared baseline levels of lipids with post-treatment lipid levels for placebo and three concentrations of phytosterols(900mg/day or 1800mg/day or 2700mg/day) following 12 weeks of treatment.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000303640